miocamycin has been researched along with trimethoprim, sulfamethoxazole drug combination in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canepari, P; Cornaglia, G; Fontana, R; Ligozzi, M; Pelosi, E | 1 |
| Bandettini, R; Debbia, EA; Marchese, A; Roveta, S | 1 |
2 other study(ies) available for miocamycin and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Drug Combinations; Enterobacteriaceae; Fluoroquinolones; Lactams; Leucomycins; Microbial Sensitivity Tests; Miocamycin; Netilmicin; Quinolones; Staphylococcus; Streptococcus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Miocamycin; Streptococcus pneumoniae; Streptococcus pyogenes; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |